10:21:34 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-05-30 Bokslutskommuniké 2024
2024-02-29 Kvartalsrapport 2024-Q3
2023-12-04 Kvartalsrapport 2024-Q2
2023-10-04 Ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 Årsstämma 2024
2023-08-31 Kvartalsrapport 2024-Q1
2023-06-08 Bokslutskommuniké 2023
2023-03-01 Kvartalsrapport 2023-Q3
2022-12-01 Kvartalsrapport 2023-Q2
2022-10-03 Ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 Årsstämma 2023
2022-08-31 Kvartalsrapport 2023-Q1
2022-06-10 Bokslutskommuniké 2022
2022-03-02 Kvartalsrapport 2022-Q3
2021-12-02 Kvartalsrapport 2022-Q2
2021-09-09 Ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 Kvartalsrapport 2022-Q1
2021-05-31 Bokslutskommuniké 2021
2021-03-03 Kvartalsrapport 2021-Q3
2020-12-02 Kvartalsrapport 2021-Q2
2020-09-30 Årsstämma 2021
2020-09-09 Ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 Kvartalsrapport 2021-Q1
2020-06-08 Bokslutskommuniké 2020
2020-04-20 Extra Bolagsstämma 2020
2020-03-02 Kvartalsrapport 2020-Q3
2019-12-02 Kvartalsrapport 2020-Q2
2019-09-30 Årsstämma 2020
2019-09-25 Ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 Kvartalsrapport 2020-Q1
2019-06-10 Bokslutskommuniké 2019
2019-03-04 Kvartalsrapport 2019-Q3
2018-12-17 Kvartalsrapport 2019-Q2
2018-09-25 Ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 Årsstämma 2019
2018-09-24 Kvartalsrapport 2019-Q1
2018-06-25 Bokslutskommuniké 2018
2018-03-26 Kvartalsrapport 2018-Q3
2017-12-18 Kvartalsrapport 2018-Q2
2017-09-25 Årsstämma 2018
2017-09-25 Kvartalsrapport 2018-Q1
2017-06-30 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Idag utvecklar bolaget system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.
2020-09-18 10:15:00

Integrum's OPRA™ Implant System is now available at Memorial Hermann Orthopaedic and Spine Hospital, Texas

Memorial Hermann Orthopaedic & Spine Hospital in Houston has launched an Osseointegration program with Integrum's OPRA™ Implant System.

Osseointegration (OI) is a life-changing surgical technique for amputees, in which an implant is anchored in the bone and directly attached to a prosthesis. OI eliminates the need for a prosthetic socket, the most challenging part of fitting a prosthesis often leading to pain and skin/soft tissue problems. OI has been shown to improve function, walking ability and overall quality of life for people with limb loss.

Integrum's OPRA™ Implant System consists of an anchorage element (Fixture) and a skin-penetrating device (Abutment). The Fixture is surgically inserted into the femur, and after a healing time of several months, the Abutment is connected to the Fixture. The prosthetic leg is then attached directly to the Abutment via the Axor™, a prosthetic connection and safety device.

"At the Center for Limb Optimization and Restoration, our interdisciplinary medical and rehabilitation team aims to provide exceptional patient care and expertise," said Danielle Melton, M.D., a specialist in the rehabilitation of people with amputations and the Director of the Amputee Program at TIRR Memorial Hermann and associate professor in the Department of Orthopaedic Surgery at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). "We are focused on improving outcomes and getting our patients one step closer to achieving their potential. We are always looking for new ways to improve our patient's quality of life."

Besides Dr. Melton, the Osseointegration program is led by a team of UTHealth orthopaedic surgeons including Matthew Koepplinger, DO, David Doherty. Jr, MD, Jim Kellam, MD and Ken Mathis, MD.

Integrum's OPRA™ Implant System is the only FDA-approved, bone-anchored prosthetic solution available in the United States.

"We are delighted to be collaborating with the team at Memorial Hermann," said Maria Lopez, CEO of Integrum. "It's an exciting time for osseointegration in the United States and we are glad to see reputable health systems like Memorial Hermann adopt the technology."

 

Memorial Hermann Orthopaedic & Spine Hospital is part of the Memorial Hermann Health System, one of the largest not-for-profit health systems in Southeast Texas with 17 hospitals and numerous specialty programs and services conveniently located throughout the Greater Houston area.

The most comprehensive academic health center in the UT System (https://www.utsystem.edu/) and the U.S. Gulf Coast region, UTHealth is home to John P. and Kathrine G. McGovern Medical School (https://med.uth.edu/), which includes the clinical practice UT Physicians (https://www.utphysicians.com/), as well as five other schools. For more information, visit www.uth.edu.
UT Physicians at Memorial Hermann Orthopaedic & Spine Hospital will be hosting an Osseointegration Clinic on Friday, Sep 18, 2020. For a referral to UT Physicians Orthopaedics at Memorial Hermann Orthopaedic & Spine Hospital, please call (713) 486-3550.

The information in this press release is information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out below, at 10:15 am on 18 Sep 2020. Integrum AB is listed on Nasdaq First North in Stockholm. Erik Penser is the Company's Certified Adviser.